Search

everythinglearnresearchcommunity

for

Search:↓

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Early balding men may have insulin resistance, but lifestyle changes can help.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Some men with early hair loss may have a condition similar to PCOS in women.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.